709 related articles for article (PubMed ID: 24817668)
1. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
[TBL] [Abstract][Full Text] [Related]
3. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
4. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib.
Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Kochi T; Suetsugu A; Shiraki M; Shimizu M
Int J Mol Sci; 2015 Apr; 16(5):9612-24. PubMed ID: 25927582
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
Meza-Junco J; Montano-Loza AJ; Baracos VE; Prado CM; Bain VG; Beaumont C; Esfandiari N; Lieffers JR; Sawyer MB
J Clin Gastroenterol; 2013; 47(10):861-70. PubMed ID: 23751844
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.
Ha Y; Kim D; Han S; Chon YE; Lee YB; Kim MN; Lee JH; Park H; Rim KS; Hwang SG
Cancer Res Treat; 2018 Jul; 50(3):843-851. PubMed ID: 28882021
[TBL] [Abstract][Full Text] [Related]
11. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis.
Begini P; Gigante E; Antonelli G; Carbonetti F; Iannicelli E; Anania G; Imperatrice B; Pellicelli AM; Fave GD; Marignani M
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):107-114. PubMed ID: 28051799
[TBL] [Abstract][Full Text] [Related]
13. Plasma free amino acids are associated with sarcopenia in the course of hepatocellular carcinoma recurrence.
Sano A; Tsuge S; Kakazu E; Iwata T; Ninomiya M; Tsuruoka M; Inoue J; Masamune A
Nutrition; 2021 Apr; 84():111007. PubMed ID: 33745507
[TBL] [Abstract][Full Text] [Related]
14. Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Bilen MA; El-Rayes BF
Am J Clin Oncol; 2021 Feb; 44(2):74-81. PubMed ID: 33350681
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
16. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia increases 1-year mortality after surgical resection of hepatocellular carcinoma.
Salman MA; Omar HSE; Mikhail HMS; Tourky M; El-Ghobary M; Elkassar H; Omar MG; Matter M; Elbasiouny AM; Farag AM; Shaaban HE; Atallah M; Elshabacy O; Salman AA
ANZ J Surg; 2020 May; 90(5):781-785. PubMed ID: 31943655
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia as a Predictive Factor for Recurrence of Hepatocellular Carcinoma Following Radiofrequency Ablation.
Jaruvongvanich V; Thamtorawat S; Saiviroonporn P; Pisanuwongse A; Siriwanarangsun P
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1143-1150. PubMed ID: 37116135
[TBL] [Abstract][Full Text] [Related]
19. Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection.
Polvieng T; Hongjinda S; Thienhiran A; Burasakarn P; Fuengfoo P
Am Surg; 2024 Jun; 90(6):1447-1455. PubMed ID: 38516765
[TBL] [Abstract][Full Text] [Related]
20. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
Takada H; Kurosaki M; Nakanishi H; Takahashi Y; Itakura J; Tsuchiya K; Yasui Y; Tamaki N; Takaura K; Komiyama Y; Higuchi M; Kubota Y; Wang W; Okada M; Enomoto N; Izumi N
PLoS One; 2018; 13(6):e0198812. PubMed ID: 29912922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
